| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/16/2004 | CA2516629A1 Compositions and methods for preventing and treating endotoxin-related diseases and conditions |
| 09/16/2004 | CA2516098A1 Oxytocin controlled release formulations and methods of using same |
| 09/16/2004 | CA2515098A1 Invisible patch for active agent controlled delivery |
| 09/15/2004 | EP1457431A2 Injection moulded water-soluble container |
| 09/15/2004 | EP1457213A1 Anthelmintic resinates and a method for their preparation |
| 09/15/2004 | EP1457208A1 Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels |
| 09/15/2004 | EP1457207A1 Solid compositions containng compounds unstable to oxygen and method for stabilization thereof |
| 09/15/2004 | EP1457202A2 Topical formulation comprising a NSAID, preferably diclofenac, for alleviating pain/inflammation caused by herpes virus infection |
| 09/15/2004 | EP1457172A1 Joint prosthesis with substained release of a therapeutic agent |
| 09/15/2004 | EP1456386A2 Polycistronic expression of antibodies |
| 09/15/2004 | EP1456377A2 Syn3 compositions and methods |
| 09/15/2004 | EP1456246A1 Chitosan-thio-amidine conjugates and their cosmetic as well as pharmaceutic use |
| 09/15/2004 | EP1456219A1 Crystalline form of a ribofuranosyluronamide derivative; a human adenosine A2a receptor agonist |
| 09/15/2004 | EP1455873A1 Metered dose inhaler |
| 09/15/2004 | EP1455839A1 Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation |
| 09/15/2004 | EP1455838A1 Process for preparation of inclusion compounds between a non-steroidal anti-inflammatory drug and betacyclodextrin by microwave treatment |
| 09/15/2004 | EP1455837A1 Pharmaceutical conjugates with enhanced pharmacokinetic characteristics |
| 09/15/2004 | EP1455836A2 Use of micro-organisms for a directed delivery of substances to specific parts of the gut |
| 09/15/2004 | EP1455835A2 Method of modulating release of saccharides and uses thereof |
| 09/15/2004 | EP1455834A2 Post-coated liposome/lipoplex for targeted drug/gene delivery and lipid linked to a delivery, targeting or stabilising moiety |
| 09/15/2004 | EP1455833A1 Chimeric molecule for the treatment of th2-like cytokine mediated disorders |
| 09/15/2004 | EP1455832A2 Pulsed bio-agent delivery systems based on degradable polymer solutions or hydrogels |
| 09/15/2004 | EP1455824A2 Lyophilized preparation containing antibodies to the egf receptor |
| 09/15/2004 | EP1455823A2 Anti-t cell immunotoxin fusion protein and its therapeutic use |
| 09/15/2004 | EP1455822A2 Lyophilized monoclonal antibody compositions |
| 09/15/2004 | EP1455810A1 Pharmaceutical formulation comprising cyclosporin and use thereof |
| 09/15/2004 | EP1455805A1 A procedure for obtaining a zinc oxide containing product for skin-healing, care and protection in children and adults |
| 09/15/2004 | EP1455786A1 Use of a compound in the treatment of sleep disorders and the like in providing refreshedness on waking and a method for the treatment of grogginess therewith |
| 09/15/2004 | EP1455782A1 High-concentration stable meloxicam solutions for needle-less injection |
| 09/15/2004 | EP1455780A1 Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma |
| 09/15/2004 | EP1455778A2 Methods for the treatment of peripheral neural and vascular ailments |
| 09/15/2004 | EP1455766A2 Thymosin alpha 1 peptide/polymer conjugates |
| 09/15/2004 | EP1455764A2 Medicinal aerosol compositions with an amide and/or ester containing excipient compound |
| 09/15/2004 | EP1455763A1 Oral capsule formulation with increased physical stability |
| 09/15/2004 | EP1455761A1 Pharmaceutical compositions for the oral administration of heparin or derivatives thereof |
| 09/15/2004 | EP1455760A1 Ultrapure oral fludara formulation with a fast releasing active substance |
| 09/15/2004 | EP1455759A2 Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration |
| 09/15/2004 | EP1455756A1 Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist |
| 09/15/2004 | EP1455755A2 Improved particulate compositions for pulmonary delivery |
| 09/15/2004 | EP1455754A2 Pharmaceutical compositions in particulate form |
| 09/15/2004 | EP1455753A1 Pharmaceutical compositions comprising a cyclosporin, a hydrophilic surfactant and a lipophilic surfactant |
| 09/15/2004 | EP1455752A2 Pharmaceutical suspension for oral administration |
| 09/15/2004 | EP1455751A1 Zero-order sustained released dosage forms and method of making the same |
| 09/15/2004 | EP1455605A1 Soft drink replacer |
| 09/15/2004 | EP1455600A1 Food or pet food composition containing plant extract for bone health |
| 09/15/2004 | EP1455596A1 Capsule with fast content solubilization and release |
| 09/15/2004 | EP1455588A1 Protein hydrolysate and plant sterol containing composition for improving serum lipid profile and preventing atherosclerosis |
| 09/15/2004 | EP1351709B1 Pegylation of linkers improves antitumor activity and reduces toxicity of immunoconjugates |
| 09/15/2004 | EP1349543B1 Method for producing tablets from plant extracts |
| 09/15/2004 | EP1200351B1 Electrolytic purification of calcium carbonate |
| 09/15/2004 | EP1089711B1 Calcium phosphate coated vesicles |
| 09/15/2004 | EP1088059B1 A polypeptide-polymer conjugate |
| 09/15/2004 | EP1073467B1 Co-solvent formulations comprising a vitamin d compound |
| 09/15/2004 | EP1071467B1 Comb copolymers for regulating cell-surface interactions |
| 09/15/2004 | EP1007095B1 CHIMERIC TOXINS COMPRISING GnRH FOR TARGETED THERAPY |
| 09/15/2004 | EP1001814B1 Controlled release microencapsulated ngf formulation |
| 09/15/2004 | EP0988046B1 Oil-free pharmaceutical compositions containing cyclosporin a |
| 09/15/2004 | EP0979104B1 Sonodynamic therapy using an ultrasound sensitizer compound |
| 09/15/2004 | EP0956004B1 Method for producing shaped and unshaped polyol masses and compositions obtained by the process |
| 09/15/2004 | EP0859601B1 Prolonged release of gm-csf |
| 09/15/2004 | EP0624195B1 Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides |
| 09/15/2004 | CN1529759A Modular transfection system |
| 09/15/2004 | CN1529613A Method for using nervous thread proteins to treat tumors and other conditions requiring removal of destruction of cells |
| 09/15/2004 | CN1529612A Targeted delivery of drugs for treatment of viral infections |
| 09/15/2004 | CN1529611A Use of IL-18 inhibitors for treatment or prevention of sepsis |
| 09/15/2004 | CN1529606A Preparation containing seleniter or selenate for treating wound |
| 09/15/2004 | CN1529603A Use of bile acid or bile salt fatty acid conjugates |
| 09/15/2004 | CN1529594A Injectable galenic formulation for use in diagnosis or photodynamic therapy and method for preparing same |
| 09/15/2004 | CN1529589A Optimised formulation of tobramycin for aeroselization |
| 09/15/2004 | CN1529588A Pharmaceutical formulation |
| 09/15/2004 | CN1529586A Controlled agglomeration |
| 09/15/2004 | CN1529585A Pharmaceutical formulation having masked taste and method for production thereof |
| 09/15/2004 | CN1529551A Substantially homogeneous bio-affecting material having predetermined ratio of bio-affecting component to cell targeting component, method for making such material and use |
| 09/15/2004 | CN1528463A Biodegradable chitosan slow-release material |
| 09/15/2004 | CN1528462A Water-soluble matrix for external transdermal paster and preparing method thereof |
| 09/15/2004 | CN1528461A Drug targeting slow-release carrier material and preparing process thereof |
| 09/15/2004 | CN1528458A Heat-resisting lyophilized protectant for chicken newcastle disease, chicken infectious bronchitis (H120, H52) dual lyophilized vaccine and preparing process thereof |
| 09/15/2004 | CN1528456A Heat resisting lyophilized protectant for chicken infectious bronchitis (H120, H52, Kidney infectious bronchitis W93) lyophilized vaccine and preparing process thereof |
| 09/15/2004 | CN1528434A Chinese medicine composition for treating myopia and preparing method thereof |
| 09/15/2004 | CN1528280A Heat-resistant lyophilized protectant of lyophilized vaccine for chicken infectious laryngotracheitis and preparing process thereof |
| 09/15/2004 | CN1528271A Method for producing bio-adhered micro-ball medicine preparation for gastrointestinal tract |
| 09/15/2004 | CN1528270A Chinese medicine cataplasm matrix and preparing technique thereof |
| 09/15/2004 | CN1166676C Injectable anthelmintic formulation |
| 09/15/2004 | CN1166597C Nitrogenous group conversion method |
| 09/15/2004 | CN1166408C Substrate tablet containing trimetzidine capable of long time controlled release after oral application |
| 09/15/2004 | CN1166407C Application of agrose in preparing medicine for prostate hyperplosia |
| 09/15/2004 | CN1166406C Composition and pharmaceutical dosage form for colonic drug delivery using polysaccharides |
| 09/15/2004 | CN1166405C Antiviral agent in form of nose drops |
| 09/15/2004 | CN1166371C Use of propionic bacteria for producing propionic acid and/or propionates in colon |
| 09/15/2004 | CN1166364C Controlled drug delivery system for diltiazem |
| 09/15/2004 | CN1166357C Base material of suppository |
| 09/14/2004 | US6791003 Dual adhesive transdermal drug delivery system |
| 09/14/2004 | US6790942 Biologically active conjugates having a detectable reporter moiety and method of identification of the derivative |
| 09/14/2004 | US6790939 Anti-PSCA antibodies |
| 09/14/2004 | US6790910 Antimicrobial polymers or blends may be used for producing hygiene items or items for medical technology, e.g. as a coating, or else in surface coatings or protective paints, water treatment |
| 09/14/2004 | US6790867 Combination of flunixin or the meglumine salt with a fluorinated chloramphenicol or thiamphenicol derivative antibiotic such as florfenicol |
| 09/14/2004 | US6790861 Mixing with hydrochloride chloride generator |
| 09/14/2004 | US6790855 Two compounds, one effecting opioid analgesia and one effecting local anesthesia, in amounts sufficient to potentiate an antinociceptive response when both compounds are topically administered |
| 09/14/2004 | US6790847 Topical application of cetirizine and loratadine |
| 09/14/2004 | US6790837 Ribavirin syrup formulations |